US equities |
MU $1,086.48 ▲+3.91% NVDA $236.90 ▼-0.98% SNDK $1,725.31 ▲+3.91% SPCX $167.70 ▼-2.45% AMD $645.50 ▼-0.60% INTC $112.67 ▲+0.15% TSLA $376.35 ▼-1.14% AAPL $337.14 ▲+1.05%
FinancialContent

XORTX Therapeutics Inc. - Common Shares (NQ:XRTX)

1.745 +0.015 (+0.87%)
Delayed Quote Updated: 2:15 PM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about XORTX Therapeutics Inc. - Common Shares

News headline image
Gout Treatments Need A Better Option: XORTX Therapeutics Is Betting XORLO Is It, Targets New Drug Application With FDA Next Year
By Meg Flippin, Benzinga 
Via NewMediaWire
XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial
Via Get News
Topics Intellectual Property
XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial
New York, NY, March 19, 2024 – (Plato Data) -- In the realm of pharmaceutical innovation, XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), stands out for its... 
Via TheNewswire.com
Topics Intellectual Property